Guide | Hydrops Fetalis: A Life-Threatening Perinatal Fluid Accumulation Syndrome
Hydrops fetalis is a critical perinatal condition characterized by abnormal fluid accumulation in a fetus or newborn, commonly in the abdomen, around the heart and lungs, and under the skin. Without timely treatment, the fluid can place severe pressure on the heart and other vital organs, potentially causing heart failure and becoming life-threatening.
Main Clinical Signs
Hydrops fetalis may be detected on prenatal imaging. Common findings include:
Abnormally increased amniotic fluid;
Thickened placenta;
Enlarged spleen and heart;
Fluid accumulation around the heart and lungs and in the abdomen.
Common symptoms after birth include:
Pale skin;
Heavy sweating and difficulty breathing;
Enlarged liver and spleen;
Visible generalized edema.
Two Main Types
Non-immune hydrops: Accounts for about 80%-90% of cases and is commonly associated with genetic disorders or congenital abnormalities that prevent the fetus from regulating fluid normally.
Immune hydrops: Less common and usually caused by maternal-fetal blood type incompatibility, such as an Rh-negative mother and Rh-positive fetus. The mother's immune system treats fetal red blood cells as foreign and destroys them, causing hemolytic anemia and, in severe cases, fetal heart failure.
Causes and Associated Conditions
Hydrops fetalis is not a disease itself but a clinical manifestation of another condition. Common associated factors include:
Hemolytic disease of the newborn (Erythroblastosis fetalis);
Severe anemia;
Intrauterine infection;
Developmental defects of the heart or lungs;
Birth defects and congenital abnormalities, which affect about 3%-4% of newborns to varying degrees;
Liver disease, often accompanied by jaundice, abdominal swelling, fever, and pain.
Diagnosis
Doctors can usually detect abnormal fluid in at least two fetal body cavities or beneath the skin during a routine prenatal ultrasound. They also assess amniotic fluid volume, placental thickness, and the size of the heart, liver, and spleen.
Maternal and fetal blood tests can also identify red blood cell type incompatibility.
Treatment and Prognosis
When hydrops fetalis is diagnosed during pregnancy, some cases cannot be treated effectively, and early delivery may be required to reduce risks to the mother and fetus.
After birth, affected newborns often require neonatal intensive care, including:
Mechanical ventilation;
Needle drainage of fluid around the heart and lungs and in the abdomen;
Treatment of the underlying cause and long-term monitoring.
Experts advise that once hydrops fetalis is diagnosed, care should be jointly managed by obstetric and neonatal intensive care teams. Early screening and prompt identification of possible blood type incompatibility and genetic disorders are essential to improving perinatal outcomes.
Guide | Hydrops Fetalis: A Life-Threatening Perinatal Fluid Accumulation Syndrome
Guide | Hydrops Fetalis: A Life-Threatening Perinatal Fluid Accumulation Syndrome
Hydrops fetalis is a critical perinatal condition characterized by abnormal fluid accumulation in a fetus or newborn, commonly in the abdomen, around the heart and lungs, and under the skin. Without timely treatment, the fluid can place severe pressure on the heart and other vital organs, potentially causing heart failure and becoming life-threatening.
Main Clinical Signs
Hydrops fetalis may be detected on prenatal imaging. Common findings include:
Abnormally increased amniotic fluid;
Thickened placenta;
Enlarged spleen and heart;
Fluid accumulation around the heart and lungs and in the abdomen.
Common symptoms after birth include:
Pale skin;
Heavy sweating and difficulty breathing;
Enlarged liver and spleen;
Visible generalized edema.
Two Main Types
Non-immune hydrops: Accounts for about 80%-90% of cases and is commonly associated with genetic disorders or congenital abnormalities that prevent the fetus from regulating fluid normally.
Immune hydrops: Less common and usually caused by maternal-fetal blood type incompatibility, such as an Rh-negative mother and Rh-positive fetus. The mother's immune system treats fetal red blood cells as foreign and destroys them, causing hemolytic anemia and, in severe cases, fetal heart failure.
Causes and Associated Conditions
Hydrops fetalis is not a disease itself but a clinical manifestation of another condition. Common associated factors include:
Hemolytic disease of the newborn (Erythroblastosis fetalis);
Severe anemia;
Intrauterine infection;
Developmental defects of the heart or lungs;
Birth defects and congenital abnormalities, which affect about 3%-4% of newborns to varying degrees;
Liver disease, often accompanied by jaundice, abdominal swelling, fever, and pain.
Diagnosis
Doctors can usually detect abnormal fluid in at least two fetal body cavities or beneath the skin during a routine prenatal ultrasound. They also assess amniotic fluid volume, placental thickness, and the size of the heart, liver, and spleen.
Maternal and fetal blood tests can also identify red blood cell type incompatibility.
Treatment and Prognosis
When hydrops fetalis is diagnosed during pregnancy, some cases cannot be treated effectively, and early delivery may be required to reduce risks to the mother and fetus.
After birth, affected newborns often require neonatal intensive care, including:
Mechanical ventilation;
Needle drainage of fluid around the heart and lungs and in the abdomen;
Treatment of the underlying cause and long-term monitoring.
Experts advise that once hydrops fetalis is diagnosed, care should be jointly managed by obstetric and neonatal intensive care teams. Early screening and prompt identification of possible blood type incompatibility and genetic disorders are essential to improving perinatal outcomes.
Source:
Compiled from online sources